Stories

Bayer receives U.S. antitrust approval for Monsanto merger

Photo credit should read jean-francois Monier/AFP/Getty Images

Bayer yesterday received U.S. antitrust approval for its $66 billion acquisition of Monsanto, based on Bayer’s commitment to sell around $9 billion in assets.

Why it's a big deal: This is the largest-ever divestiture related to antitrust enforcement, and shows how the Trump administration's antipathy toward mega-mergers isn't limited to media or China.